109 related articles for article (PubMed ID: 31513020)
21. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN
Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885
[TBL] [Abstract][Full Text] [Related]
22. Activation of Pregnane X Receptor Sensitizes Mice to Hemorrhagic Shock-Induced Liver Injury.
Xie Y; Xu M; Deng M; Li Z; Wang P; Ren S; Guo Y; Ma X; Fan J; Billiar TR; Xie W
Hepatology; 2019 Sep; 70(3):995-1010. PubMed ID: 31038762
[TBL] [Abstract][Full Text] [Related]
23. Sequences of intestinal and hepatic cytochrome P450 3A4 cDNAs are identical.
Lown KS; Ghosh M; Watkins PB
Drug Metab Dispos; 1998 Feb; 26(2):185-7. PubMed ID: 9456307
[TBL] [Abstract][Full Text] [Related]
24. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes.
Renwick AB; Lavignette G; Worboy PD; Williams B; Surry D; Lewis DF; Price RJ; Lake BG; Evans DC
Xenobiotica; 2001 Dec; 31(12):861-78. PubMed ID: 11780761
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes.
Shiraga T; Matsuda H; Nagase K; Iwasaki K; Noda K; Yamazaki H; Shimada T; Funae Y
Biochem Pharmacol; 1994 Feb; 47(4):727-35. PubMed ID: 7510480
[TBL] [Abstract][Full Text] [Related]
28. Effect of a high cornstarch diet on hepatic cytochrome P450 2C and 3A activity and progesterone half-life in dairy cows.
Lemley CO; Wilmoth TA; Tager LR; Krause KM; Wilson ME
J Dairy Sci; 2010 Mar; 93(3):1012-21. PubMed ID: 20172221
[TBL] [Abstract][Full Text] [Related]
29. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
[TBL] [Abstract][Full Text] [Related]
30. Effects of Chronic Renal Failure on Brain Cytochrome P450 in Rats.
Naud J; Harding J; Lamarche C; Beauchemin S; Leblond FA; Pichette V
Drug Metab Dispos; 2016 Aug; 44(8):1174-9. PubMed ID: 27271372
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer.
Charles KA; Rivory LP; Brown SL; Liddle C; Clarke SJ; Robertson GR
Clin Cancer Res; 2006 Dec; 12(24):7492-7. PubMed ID: 17189422
[TBL] [Abstract][Full Text] [Related]
32. Interaction of methadone with substrates of human hepatic cytochrome P450 3A4.
Iribarne C; Dréano Y; Bardou LG; Ménez JF; Berthou F
Toxicology; 1997 Feb; 117(1):13-23. PubMed ID: 9020195
[TBL] [Abstract][Full Text] [Related]
33. Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Xenobiotica; 2001 Oct; 31(10):713-23. PubMed ID: 11695850
[TBL] [Abstract][Full Text] [Related]
34. In vivo effect of triptolide combined with glycyrrhetinic acid on rat cytochrome P450 enzymes.
Han FM; Peng ZH; Wang JJ; Chen Y
Yao Xue Xue Bao; 2013 Jul; 48(7):1136-41. PubMed ID: 24133982
[TBL] [Abstract][Full Text] [Related]
35. The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction.
Ling S; Jamali F
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):24-9. PubMed ID: 19371259
[TBL] [Abstract][Full Text] [Related]
36. Ethylmorphine N-demethylase activity as a marker for cytochrome P450 CYP3A activity in rat hepatic microsomes.
Amacher DE; Schomaker SJ
Toxicol Lett; 1998 Jan; 94(2):115-25. PubMed ID: 9574808
[TBL] [Abstract][Full Text] [Related]
37. Intestinal and hepatic metabolic activity of five cytochrome P450 enzymes: impact on prediction of first-pass metabolism.
Galetin A; Houston JB
J Pharmacol Exp Ther; 2006 Sep; 318(3):1220-9. PubMed ID: 16763093
[TBL] [Abstract][Full Text] [Related]
38. Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats.
Chen J; Robertson G; Field J; Liddle C; Farrell GC
Hepatology; 1998 Sep; 28(3):624-30. PubMed ID: 9731550
[TBL] [Abstract][Full Text] [Related]
39. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
[TBL] [Abstract][Full Text] [Related]
40. Estimation of fractions metabolized by hepatic CYP enzymes using a concept of inter-system extrapolation factors (ISEFs) - a comparison with the chemical inhibition method.
Umehara KI; Huth F; Gu H; Schiller H; Heimbach T; He H
Drug Metab Pers Ther; 2017 Dec; 32(4):191-200. PubMed ID: 29176011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]